272 related articles for article (PubMed ID: 2492902)
1. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
Klinge CM; Bambara RA; Zain S; Hilf R
Cancer Res; 1989 Mar; 49(5):1165-70. PubMed ID: 2492902
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor binding to nuclei from normal and neoplastic rat mammary tissues in vitro.
Klinge CM; Bambara RA; Zain S; Hilf R
Cancer Res; 1987 Jun; 47(11):2852-9. PubMed ID: 3105869
[TBL] [Abstract][Full Text] [Related]
3. Regulation of estrogen-binding capacity by insulin in 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Gibson SL; Hilf R
Cancer Res; 1980 Jul; 40(7):2343-8. PubMed ID: 6770998
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors.
Tsai TL; Katzenellenbogen BS
Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032
[TBL] [Abstract][Full Text] [Related]
5. Relationship between insulin and estrogen binding to growth response in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
Shafie SM; Hilf R
Cancer Res; 1978 Mar; 38(3):759-64. PubMed ID: 414834
[TBL] [Abstract][Full Text] [Related]
6. Influence of hormonal alteration of host on estrogen-binding capacity in 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
Gibson SL; Hilf R
Cancer Res; 1976 Oct; 36(10):3736-41. PubMed ID: 133755
[TBL] [Abstract][Full Text] [Related]
7. Inverse relation between estrogen receptors and cyclic adenosine 3':5'-monophosphate-binding proteins in hormone-dependent mammary tumor regression due to dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
Bodwin JS; Clair T; Cho-Chung YS
Cancer Res; 1978 Oct; 38(10):3410-3. PubMed ID: 210938
[TBL] [Abstract][Full Text] [Related]
8. Influence of prenatal exposure to diethylstilbestrol on estrogen and progestin binding proteins in uteri and dimethylbenzanthracene- induced mammary tumors of the rat.
Heidemann PH; Wittliff JL; Calhoon RE; Boylan ES
J Toxicol Environ Health; 1981 Oct; 8(4):667-86. PubMed ID: 6802985
[TBL] [Abstract][Full Text] [Related]
9. Specific estrogen binding in rat mammary tumors induced by 7,12-dimethylbenz(a)anthracene.
Boylan ES; Wittliff JL
Cancer Res; 1975 Mar; 35(3):506-11. PubMed ID: 163681
[TBL] [Abstract][Full Text] [Related]
10. Nuclease sensitivity of estradiol-charged estrogen receptor binding sites in nuclei isolated from normal and neoplastic rat mammary tissues.
Klinge CM; Bambara RA; Zain S; Hilf R
J Steroid Biochem; 1990 Jun; 36(1-2):7-14. PubMed ID: 2194077
[TBL] [Abstract][Full Text] [Related]
11. Opposite effects of dehydroepiandrosterone on the growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
Boccuzzi G; Aragno M; Brignardello E; Tamagno E; Conti G; Di Monaco M; Racca S; Danni O; Di Carlo F
Anticancer Res; 1992; 12(5):1479-83. PubMed ID: 1444210
[TBL] [Abstract][Full Text] [Related]
12. Steroid metabolism and steroid receptors in dimethylbenz(a)anthracene-induced rat mammary tumors.
Eechaute W; de Thibault de Boesinghe L; Lacroix E
Cancer Res; 1983 Sep; 43(9):4260-5. PubMed ID: 6409401
[TBL] [Abstract][Full Text] [Related]
13. Steroid-binding proteins of the mammary gland and their clinical significance in breast cancer.
Wittliff JL; Mehta RG; Boyd PA; Goral JE
J Toxicol Environ Health Suppl; 1976; 1():231-56. PubMed ID: 186628
[TBL] [Abstract][Full Text] [Related]
14. Biological characteristics and estrogen and progesterone receptors in mammary carcinoma induced in male Sprague-Dawley rats by a series of intragastric intubations of 7,12-dimethylbenz(a)anthracene.
Yoshida H; Yoshida A; Fukunishi R; Sato B; Okamoto S; Matsumoto K
Cancer Res; 1982 Jun; 42(6):2434-9. PubMed ID: 6804090
[TBL] [Abstract][Full Text] [Related]
15. Effect of pharmacological doses of estrogen on ovary-independent rat mammary carcinoma containing estrogen and progesterone receptors.
Yoshida H; Fukuhara T; Yamashi S; Yoshida A; Fukunishi R; Tsuji M; Matsumoto K
Cancer Res; 1983 May; 43(5):2311-6. PubMed ID: 6403234
[TBL] [Abstract][Full Text] [Related]
16. Antiestrogen(4-hydroxytamoxifen)-charged estrogen receptor binding to nuclei from normal and neoplastic rat mammary tissues is not affected by host hormonal status.
Klinge CM; Knox DT; Bambara RA; Zain S; Hilf R
J Steroid Biochem; 1989 Sep; 33(3):335-40. PubMed ID: 2779224
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptors in androgen-induced breast tumor regression.
Zava DT; McGuire WL
Cancer Res; 1977 Jun; 37(6):1608-10. PubMed ID: 192456
[TBL] [Abstract][Full Text] [Related]
18. Effective sequential administration of tamoxifen and medroxyprogesterone acetate for 7,12-dimethylbenz[a-anthracene-induced rat mammary tumors in relation to hormone receptors.
Tominaga T; Yoshida Y; Kitamura M; Kosaki G
Jpn J Cancer Res; 1985 Nov; 76(11):1120-5. PubMed ID: 2935517
[TBL] [Abstract][Full Text] [Related]
19. Androgen effects mediated by estrogen receptor in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
Garcia M; Rochefort H
Cancer Res; 1978 Nov; 38(11 Pt 1):3922-9. PubMed ID: 100211
[No Abstract] [Full Text] [Related]
20. Antitumoral and endocrine effects of (+)-vorozole in rats bearing dimethylbenzanthracene-induced mammary tumors.
De Coster R; Van Ginckel RF; Callens MJ; Goeminne NK; Janssens BL
Cancer Res; 1992 Mar; 52(5):1240-4. PubMed ID: 1737385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
